Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-30
SponsorNigde Omer Halisdemir University
About this trial
This randomized, sham-controlled trial aims to evaluate the effects of self-administered acupressure on menstrual pain severity and premenstrual symptoms in women aged 18-30 years with primary dysmenorrhea. Participants will be randomly assigned to either a self-acupressure intervention group or a sham self-acupressure control group. The intervention will be applied during the premenstrual and menstrual periods over approximately six months. The primary outcome is the change in menstrual pain severity, and secondary outcomes include changes in premenstrual symptom severity, analgesic use, and menstruation-related activity limitation.
Eligibility criteria
Qualifiers
Female participants aged 18 to 30 years
Regular menstrual cycles (21-35 days)
Diagnosis of primary dysmenorrhea with moderate to severe menstrual pain
Presence of premenstrual symptoms consistent with premenstrual syndrome
Disqualifiers
Secondary dysmenorrhea (e.g., endometriosis, uterine fibroids, pelvic inflammatory disease)
Current use of hormonal contraceptives or hormonal therapy within the past 3 months
Pregnancy or breastfeeding
Chronic gynecological, endocrine, or systemic disease that may affect menstrual pain or symptoms
Trial design
Treatments tested in this trial
- Self-Acupressure
- Sham Self-Acupressure
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov